// App-Quantinova.ai

57 : Longitudinal Immunogenomic Profiling of Tumor and Immune Cells for Minimally-Invasive Monitoring of Smoldering Multiple Myeloma (SMM): The Immunocell Study

Researchers

Presenter

  • Rosalinda Termini

Principal Investigators

  • Albert Prez

  • Tomas Jelinek

  • Nikoletta-Aikaterini Kokkali

  • Joan Bargay

  • Fernando Solano Ramos

  • Sara Rodrguez

  • Cristina Prez Ruiz

  • Catarina Maia

  • Antonio Sacco

  • Marco Chiarini

  • Viviana Giustini

  • Jill Corre

  • Francois Vergez

  • Marc S. Raab

  • Niels Weinhold

  • Aitziber Lopez Lopez

  • Sonia Garate

  • Diego Alignani

  • Sarvide Sarai

  • Remco Loos

  • Antoni Garcia-Guion

  • Maialen Sirvent

  • Jos Enrique de la Puerta

  • Rebeca Iglesias

  • Maria Casanova

  • Maria Elena Cabezudo

  • Valentin Cabaas

  • Enrique M. Ocio

  • Joaquin Martinez-Lopez

  • Javier de la Rubia

  • Artur Paiva

  • Helena Vitoria

  • Catarina Geraldes

  • Roman Hajek

  • Heinz Ludwig

  • Hartmut Goldschmidt

  • Herve Avet-Loiseau

  • Aldo M. Roccaro

  • Jess F. San-Miguel

  • Bruno Paiva

Medical Centers

  • Centro de Investigacion Medica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain

  • National & Kapodistrian University of Athens, School Medicine, Athens, Greece

  • Hospital Universitario Son Espases, Palma de Mallorca, Spain

  • Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

  • Department of Hematology, Son Llatzer University Hospital/ IdISBa, Palma de Mallorca, Spain

  • Hospital Nuestra Sra. del Prado, Talavera de la Reina, Spain

  • Centro de Investigacion Medica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain

  • Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

  • Clinical Chemistry Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy

  • CREA Laboratory; Clinical Chemistry Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy

  • Unite de Genomique du Myelome, IUCT-oncopole, Toulouse, France

  • Hematology Laboratory, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France

  • Max-Eder Group, Experimental Therapies for Hematologic Malignancies, German Cancer Research Center DKFZ, Heidelberg, Germany

  • Dept. of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

  • Celgene, Sevilla, Spain

  • Hospital Universitari Arnau de Vilanova, Lleida, Spain

  • Hospital Universitario Donostia, San Sebastian, Spain

  • Hospital de Galdakao, Bizkaia, Spain

  • MD ANDERSON CANCER CENTER, MADRID, Spain

  • Hematology Department, Hospital Costa del Sol Marbella, Marbella, Spain

  • Hospital Sant Joan Despi-Moises Broggi, Sant Joan Despi, Barcelona, Spain

  • Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain

  • Oncology Department, Hospital Universitario de Salamanca, Salamanca, Spain

  • University Hospital Marqués de Valdecilla, IDIVAL, University of Cantabria, CIBERSAM, Psychiatry, Santander, Spain

  • Hematology and hemotherapy department, Hospital Universitario HLA Moncloa, Madrid, Spain

  • Hematology Department, Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain

  • Unidade de Gestão Operacional em Citometria, Centro Hospitalar e Universitário de Coimbra (CHUC),Coimbra,Portugal

  • Serviço de Hematologia Clínica,Centro Hospitalar Tondela-Viseu,Viseu,Portugal

  • University Hospital, Ostrava, Czech Republic

  • Wilheminen Hospital, Vienna, Austria

  • Unite de Genomique du Myelome, IUCT-oncopole, Toulouse, France

  • Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Clinica Universidad de Navarra, Pamplona, Spain

Locations

  • Spain

  • Greece

  • Czech Republic

  • Italy

  • France

  • Germany

  • Portugal

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Smoldering myeloma

Biomarkers

  • Nerve Growth Factor

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved